RELX has a Low Morningstar Uncertainty Rating given its portfolio of moaty businesses in relatively mature markets. The company has low cyclicality. Most of its products are sold via subscriptions, ...

Duhamel, 52, has spent the past few years building an off-grid haven in the Land of 10,000 Lakes, having turned his back on the glamour of Hollywood in order to "get back to the basics" and, in doing ...

Dutch grocer Ahold Delhaize said it made leadership changes at some of its portfolio brands including supermarket chain Albert Heijn and online retail platform Bol.

Sales rose 11% to 9.895 billion euros on higher demand for its blockbuster anti-inflammatory drug Dupixent. Sales of Dupixent rose 20% to 3.48 billion euros, slightly up from analysts' expectations of ...

The European chip maker said revenue should come in at about $2.71 billion in the second quarter, down more than 16% year-on-year, but 7.7% higher from the first quarter. Its gross margin--a closely ...

Kering’s pricing power is strong, resulting in gross margins at the higher end of the peer range (mid-70% reported and in the 80% range, channel-adjusted). Absolute pricing of Gucci’s handbags is in ...

Anglo American backed its full-year production guidance as first-quarter copper and iron ore production was in line with expectations. The company said it continues to simplify its portfolio and that ...

"China and the United States have not held consultations or negotiations on the tariff issue, let alone reached an agreement," Chinese foreign ministry spokesperson Guo Jiakun said at a press briefing ...

The robot division is Fanuc's largest business by sales, and the company is considered one of the big four in the industrial robotics space. The growth of the industrial robotics industry is being ...

Shares in Galderma rose on Thursday after the Swiss skincare company posted higher first-quarter sales that beat expectations. In morning European trading, shares rose 6.2% to 85.60 Swiss francs. For ...

Business sentiment in Germany unexpectedly edged up in April, likely an endorsement from firms of government policies to boost spending on defense and investments, despite the market turmoil prompted ...

To strengthen its U.S. presence, Roche is building up inventory, ramping up production at three of its U.S. plants and relocating one manufacturing site to the U.S. through a technology transfer, its ...